HG-1180

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1180

Drug Alias NameBLC modulator (Human Genome Sciences)BLRI/1L modulator (Human Genome Sciences)CXCL13 modulator (Human Genome Sciences)SCYB13 modulator (Human Genome Sciences)small inducible cytokine subfamily B, member 13 (Human Genome Sciences) +[11]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-X-C motif chemokine 13 modulators

TargetsC-X-C motif chemokine 13

Therapy Area/IndicationsImmune System DiseasesCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesCardiovascular Diseases

Other Information

ATC CodeN/A